Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
暂无分享,去创建一个
F. Glorieux | H. Cheong | E. Sochett | M. Whyte | J. Simmons | A. Biggin | N. Namba | K. Muroya | O. Nilsson | W. Högler | R. Padidela | C. Munns | L. Ward | A. Portale | Farzana Perwad | G. Gottesman | P. Pitukcheewanont | E. Imel | Javier San Martin | M. Mao | A. Skrinar | Hiroyuki Tanaka | Chao‐Yin Chen